July 1-4, 2024

Nantes, FRANCE

Registration is closed.

Over four days, 20 participants will deepen their knowledge in some of the main fields of nuclear medicine research, with a focus on alpha-emitting radionuclides (astatine-211 and others).

They have the opportunity to meet some of the best international experts in radiopharmaceuticals production, artificial intelligence for medical image analysis, and theranostic approaches.

Lectures, practical works and visits take place in four major research centres in nuclear medicine in Nantes : Arronax, Faculté des Sciences et des Techniques, Centrale Nantes and Institut de Recherche en Santé.

This event is co-organized by COST NOAR Action CA19114

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. www.cost.eu

Mis à jour le 03 June 2024.